Emulating control arms for cancer clinical trials using external cohorts created from electronic health record-derived real-world data

Tan, K, Bryan, J, Segal, BD, Bellomo, L, Nussbaum, NC, Tucker, MG, Torres, AZ, Bennette, CS, Capra, WB, Curtis, MD, Miksad, RA

July 2021

Manuscript

Clinical Pharmacology and Therapeutics

Flatiron-authored

May 2021

Manuscript

Health Services Research

Flatiron-authored

February 2021

Manuscript

European Journal of Haematology

December 2020

Abstract

American Society of Hematology Annual Meeting

Redefining the prognostic significance of t(11,14) multiple myeloma

Giri, S, Costa, LJ, Godby, KN, Bhatia, S, Williams, G

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

Treatment patterns and outcomes of multiple myeloma (MM) with chromosome translocation (11,14) in United States routine clinical practice

Atrash, S, Flahavan, EM, Xu, T, Ma, E, Karve, S, Hong, W, Jirau-Lucca, G, Nixon, M, Ailawadhi, S

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

October 2020

Manuscript

Leukemia and Lymphoma

Daratumumab-lenalidomide-dexamethasone vs standard-of-care regimens: Efficacy in transplant-ineligible untreated myeloma

Durie, BGM, Kumar, S, Usmani, SZ, Nonyane, BAS, Ammann, EM, Lam, A, Kobos, R, Maiese, EM, Facon, T

August 2020

Manuscript

American Journal of Hematology (AJH)

Patient characteristics, treatment patterns, and outcomes in patients with triple-class-refractory multiple myeloma

Mehra, M, Vogel, M, Valluri, S, Nair, S, Schecter, J, Slowik, R, Jagannath, S, Weisel, K, Usmani, SZ

June 2020

Abstract

Congress of the European Hematology Association

Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents

Giri, S, Huntington, SF, Wang, R, Zeidan, AM, Podoltsev, NA, Gore, SD, Ma, X, Gross, CP, Davidoff, AJ, Neparidze, N

May 2020

Manuscript

Blood Advances

May 2020

Abstract

ASCO Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2019

Abstract

American Society of Hematology Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2019

Abstract

American Society of Hematology Annual Meeting

Patient characteristics, treatments, and transplant frequency in newly-diagnosed (NDMM) multiple myeloma

Karve, S, Downer, MK, Kamalakar, R, Maher, J, Pauff, J, Maciag, P, Gasparetto, C

June 2019

Abstract

Congress of the European Hematology Association

Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents

Giri S, Huntington SF, Wang R, Zeidan AM, Podoltsev NA, Gore S, Ma X, Gross CP, Davidoff AJ, Neparidze N

June 2019

Abstract

ASCO Annual Meeting

Overall survival with oral selinexor plus low dose dexamethasone in patients with triple class refractory-multiple myeloma

Richardson PG, Jagannath S, Chari A, Vogl DT, Dimopoulos MA, Moreau P, Dingli D, Wei LJ, Li L, Tang S, Reichman W, Kauffman MG, Shah JJ, Shacham S, Lonial S.

June 2019

Abstract

ASCO Annual Meeting

June 2019

Abstract

ASCO Annual Meeting

April 2019

Abstract

AACR Annual Meeting

Flatiron-authored

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States

McGrath LJ, Hernandez RK, Overman R, Reams D, Liede A, Brookhart MA, O’Donnell E, Leah J

December 2018

Manuscript

Cancer Medicine

December 2018

Abstract

Blood Journal

Flatiron-authored

December 2018

Abstract

Blood Journal

Flatiron-authored

December 2018

Abstract

American Society of Hematology Annual Meeting

December 2018

Abstract

Blood Journal

December 2018

Abstract

Blood Journal

December 2018

Abstract

Blood Journal

August 2018

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

August 2018

Manuscript

Supportive Care in Cancer

June 2018

Abstract

ASCO Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Oncology

December 2016

Abstract

American Society of Hematology Annual Meeting

Real-World Bortezomib Usage Patterns Among Patients with Relapsed/Refractory Multiple Myeloma

Calkins G, Kohansimeh J, Krishna A, Green R, Curtis MD, Lindberg F, Jaskiw A, Larrabee K, Terry M, Feinstein RN, Plotkin L, Palladino ML, Nicacio L

June 2015

Abstract

EHA Learning Center

Flatiron-authored